GV 2021 Gp, L.P., 10% Owner at Prime Medicine, Inc. (PRME), sold 143,080 shares at $15.13 ($1.3M) on 2023-06-13, disclosed to the SEC on 2023-06-15.
Scheduled sale ($1.3M) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 28,100 | $0 | 0.0% |
| 2 | $15.13 | 28,100 | $425K | 33.0% |
| 3 | $0.00 | 28,960 | $0 | 0.0% |
| 4 | $14.87 | 28,960 | $431K | 33.5% |
| 5 | $14.87 | 28,960 | $431K | 33.5% |
| Total | $8.99 avg | 143,080 |
| $1.3M |
| 100% |
| Filing → |
| PRME | SELL | 2023-06-07 | $1.8M | — | Filing → |
| PRME | SELL | 2023-05-22 | $2.5M | — | Filing → |
| PRME | SELL | 2023-05-10 | $11.9M | — | Filing → |